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Background: In resource-limited settings where healthcare services are limited and poverty is common, it is
difficult to ethically conduct clinical research without providing patient-care. Therefore, integration of patient-care
with clinical research appears as an attractive way of conducting research while providing patient-care. In this
article, we discuss the ethical implications of such approach with perspectives from Papua New Guinea.
Discussion: Considering the difficulties of providing basic healthcare services in developing countries, it may be
argued that integration of clinical research with patient-care is an effective, rational and ethical way of conducting
research. However, blending patient-care with clinical research may increase the risk of subordinating patient-care
in favour of scientific gains; therapeutic misconception and inappropriate inducement; and the risk of causing
health system failures due to limited capacity in developing countries to sustain the level of healthcare services
sponsored by the research. Nevertheless, these ethical and administrative implications can be minimised if
patient-care takes precedence over research; the input of local ethics committees and institutions are considered;
and funding agencies acknowledge their ethical obligation when sponsoring research in resource-limited settings.
Summary: Although integration of patient-care with clinical research in developing countries appears as an
attractive way of conducting research when resources are limited, careful planning and consideration on the ethical
implications of such approach must be considered.
Keywords: Developing countries, Resource-limited settings, Papua New Guinea, Ethical challenges, Therapeutic
misconception, InducementBackground
Developing countries carry a high proportion of the
global disease burden and are increasingly becoming at-
tractive sites for clinical research because of better
funding in recent years [1]. On the contrary, research
regulations in developed countries are becoming more
restrictive, making research in the third world appear
more attractive [2]. In view of this, the Council for Inter-
national Organizations of Medical Sciences (CIOMS) in
collaboration with the World Health Organization
(WHO) developed the international ethical guidelines
for biomedical research involving human subjects be-
cause of concerns with increasing research activities in* Correspondence: drmlaman@yahoo.com
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reproduction in any medium, provided the orthird world countries [3]. The CIOMS guideline high-
lights ethical challenges with regards to the informed
consent process, inappropriate inducement, vulnerable
populations, post-trial access and therapeutic miscon-
ception. Although the guideline was developed to pro-
tect vulnerable populations in developing countries from
exploitation, data on ethical issues affecting these set-
tings are limited.
Therapeutic misconception is an example of an ethical
challenge with limited data from a developing country’s
perspective and refers to the tendency of participants in
clinical research to confuse the conduct of research with
medical care [4]. The term was originally used in
randomised controlled clinical trials but is now widely
used amongst researchers in various fields [5]. The confu-
sion is particularly common when a clinician performing
clinical research is also the patient’s healthcare providerLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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often encountered in resource-limited settings. In clinical
research, appropriate inducement is considered acceptable
if used as an incentive to improve the conduct of a study
without coercion or harm to the patient and there is in-
formed consent [3].
In developed countries where healthcare services are
adequately funded, efficient and easily accessible, ethical
challenges are less complex compared to developing
countries. In developing countries, constant shortage of
resources and failures in the healthcare system compli-
cated by high rates of poverty and illiteracy often creates
a more challenging situation [7-9]. In such settings, it
may be argued that integrating patient-care with clinical
research may be the most rational method of providing
quality patient-care while consenting and recruiting
patients. However, whether this approach of conducting
research would be considered ethical or not is debatable
depending on contextual differences between different
settings and the nature of the research performed [10].
In this article, we specifically attempt to discuss ethical
challenges often encountered during integration of clin-
ical research with patient-care in developing countries,
with perspectives from Papua New Guinea (PNG).
Discussion
Challenges in developing countries such as Papua New
Guinea
Developing countries continue to bear a large propor-
tion of the global disease burden with high morbidity
and mortality rates [11]. Papua New Guinea is one such
country in the Oceania region where 85% of its 7 million
inhabitants reside in remote settings with limited
healthcare services [12]. Its rugged mountainous ter-
rains, dense rainforests, lowland swamps and remote
atoll islands contribute to the inequalities and challenges
of providing even the most basic healthcare service in
PNG [12,13]. Complicated by deteriorating infrastruc-
ture and government services, late presentation to hos-
pital often results in high maternal mortality rates [14].
Pneumonia, malaria, meningitis, malnutrition, sepsis and
low birth weight are major causes of death in children
<5 years of age [15]. Despite supplementary vaccination
campaigns, immunization coverage for preventable fatal
diseases like measles remain <70% and post-measles
complications presenting as sub-acute sclerosing panen-
cephalitis is considered to be the highest worldwide
[16]. Four of the five known plasmodia species that cause
malarial infections in humans co-exist in PNG [17].
Streptococcus pneumoniae and Haemophilus influenzae
are leading causes of pneumonia and acute bacterial men-
ingitis [18-20]. Although the Haemophilus influenzae type
B vaccine was introduced in 2007, pneumococcal vaccine
is not yet part of the vaccination schedule [21]. Unlike inAfrican settings, the overall HIV prevalence in PNG is <1%
[22], but tuberculosis is a major public health problem and
the increasing incidence of multidrug-resistant tuberculosis
continues to be a great concern [23]. Neglected tropical
diseases such as yaws, helminthic infestations, scabies,
lymphatic filariasis, trachoma, leprosy, cholera and dengue
also contribute to a significant burden of morbidity and
mortality in this population [24].
Considering these major challenges in providing basic
healthcare services in a country such as PNG where the
doctor to patient ratio is 0.49/10,000 [25], it would seem
unethical for a researcher to turn away patients or reserve
resources only for use in study patients when confronted
with patients in desperate need of basic healthcare
services. In such situations, integration of patient-care
with clinical research appears as an effective, rational and
ethical method of conducting research.
Ethical implications of integrating patient-care with
clinical research
i. The risk of subordinating patient-care in favour of
scientific gain
Although integration of patient-care with clinical re-
search appears attractive, there are important ethical im-
plications that must be considered. Acceptance of this
method of conducting research may lead to widespread
exploitation of vulnerable people with limited options in
developing countries particularly due to the temptation
to subordinate the patient’s welfare to the objectives of
the study. This is possible when the objectives of the re-
search are extremely important with a high probability
of improving the care of future patients [10]. In view of
this risk, the declaration of Helsinki clearly states that
the interest of science should never take precedence
over the wellbeing of patients [26]. The Tuskegee syphilis
study is a classic example of subordinating patient-care for
the interest of science [27]. In that study, patients with
syphilis were denied the best known treatment in their
setting in favour of scientific gain. The justification pro-
vided by the investigators was that these patients would
not have been treated if they were not in the study be-
cause of their low socioeconomic status.
In a similar instance, a randomised controlled trial in
Uganda raised serious ethical concerns for observing
HIV infected patients without treating them for over
30 months [28]. In addition, patients in that study found
to have other sexually transmitted infections had to seek
their own treatment, while HIV seronegative partners of
HIV patients were not informed. Such examples high-
light the fact that even with the most altruistic of
motives, the risk of subordinating patient-care in favour
of important research findings may become a real threat
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resource-limited settings.
ii. The risk of therapeutic misconception and
inappropriate inducement
The risk of therapeutic misconception and inappropriate
inducement in developing countries where illiteracy and
poverty are common is also substantial. On the contrary,
in well-resourced settings where healthcare services are
well established and easily accessible, therapeutic miscon-
ception is perhaps easy to define since the role of a
healthcare physician is distinctly different from the role of
a research clinician. However, in resource-limited settings,
often there is no clear distinction between a health service
provider and a medical researcher and this often creates
confusion, increasing the likelihood of therapeutic mis-
conception. In addition, when clinical studies provide
healthcare services, it may serve as an inappropriate in-
ducement or coercion to potential participants particularly
when patients are poor and such standard of healthcare
services are limited or unavailable in their locality [29].
This will raise serious concerns regarding the ethical stan-
dards of the study.
iii. Challenges of sustaining health services funded by
clinical studies
When clinical studies performed in resource-limited set-
tings conform to the highest standard of care attainable in
the local setting, the study is often considered as advanta-
geous [29]. However, the challenge of sustainability comes
after the research project ends. Because research projects
often have limited lifespan and funding agencies do not
provide funds for patient-care, the high standard set by
the study would create undue stress on the health re-
sources and infrastructure of the locality. In addition, the
health system and workforce that have become dependent
on the integrated research team and its resources will now
have to perform without that support. Furthermore, since
the expected roles and responsibilities of researchers col-
laborating with the health service providers are often not
discussed explicitly and understood before the integration
process at the start of the study, this often contributes to
failures in the health system in resource-limited settings.
Way forward in minimising ethical challenges
i. Importance of developing country ethics committees
and institutions
The role of an ethics committee in a developing coun-
try in thoroughly reviewing research proposals is the
most important step and often the only opportunity todetermine the ethical and scientific aspects of a research
proposal. This is mainly due to financial constrains in
actively monitoring research projects, lack of experience
(many ethics committees have existed for less than a
decade as is the case in our setting), and lack of scien-
tific expertise [30]. Nevertheless, ethics committees have
played an important role in recent years in resource-
limited settings in safeguarding the rights, safety and
well-being of study participants.
Considering the ethical implications of integrating
clinical research with patient-care, where possible, devel-
oping country ethics committees must find the balance
between pushing for the highest standard of patient-care
practically attainable in the host country to be given to
study patients, while at the same time making sure the
study does not harm the local healthcare system when
sustainability is no longer possible at the completion of
the study. This is of paramount importance since ethics
committees in developed countries that approve clinical
studies to be conducted in resource-limited settings in
contrast, rarely understand the practicalities in resource-
limited settings. Additionally, they do not have expertise
in performing field research under challenging condi-
tions and rarely understand the cultural issues involved
in protecting study participants in resource-limited set-
tings [30]. Therefore, without the input of local ethics
committees, it would be difficult to contextualize and
avoid ethical complications that may arise in resource-
limited settings.
Furthermore, the research may find its greatest applica-
tion only in developed countries but not in developing
countries. For instance, a great deal of work on pneumo-
nia research that has led to the development of the WHO
guidelines for pneumonia in children and scientific data
contributing to the development of pneumococcal vac-
cines in developed countries was pioneered in PNG since
the 1960s [31]. Yet Papua New Guineans have not reaped
the benefits of these research; pneumococcal vaccine is
still unavailable in PNG after 50 years of research and
pneumonia remains the leading cause of death in PNG
children [32], the very reason that justified doing pneumo-
nia research in PNG in the first place. Though this reflects
many political and economic factors as well as the un-
ethical trend of research in the past, these experiences
have strengthened developing country research institu-
tions such as the Papua New Guinea Institute of Medical
Research and national ethics committees to ensure future
research benefit both developing and developed countries.
ii. Community participation
In developed countries, autonomy is vital and a partici-
pant’s right is fundamental during the informed consent
process [30]. However, in developing countries, community
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process often precedes an individual informed consent
process. For instance, in communities within PNG, without
community consent it would be impossible to conduct
research and misconceptions will be inevitable [33].
Complicated by high rates of illiteracy, whether a patient is
formally educated enough to understand basics of a study
concept in order to make an informed choose is challen-
ging and further raises ethical questions. In a male domi-
nated society, as is the case in many developing countries,
often autonomy comes into conflict with beneficence, more
commonly when a mother expects a male clinician or re-
searcher to decide on her behalf. Consequently, community
consent is an integral part of the informed consent process
in developing country settings that must be emphasised.
iii. Minimising the risk of therapeutic misconception
and inappropriate inducement
In a study investigating therapeutic misconception in
Malawi, patients in a clinical trial rationally decided to
participate because they wanted ‘better’ quality health-
care and not because of misconceptions [34]. This high-
lights the fact that even in settings where illiteracy is
common, therapeutic misconceptions can be minimised
if the informed consent process is facilitated by a com-
petent person who understands the culture and language
of the potential participant. However, this also highlights
that when healthcare services are integrated with clinical
research, the study may be perceived as a powerful in-
ducement particularly if the standard of care provided
by the clinical research is unavailable in the local setting.
Similarly, in PNG where the standards of care pro-
vided by well-funded research projects are often not
comparable to poorly funded routine clinical care, pa-
tients usually enrol into clinical studies for what they
think is ‘better’ clinical care. For instance, a simple full
blood count examination often performed in patients in
well-resourced settings as part of routine investigations
is not routinely available even in some provincial hospi-
tals in PNG. Continuous shortage of pharmaceuticals
and infrastructure difficulties make simple healthcare in-
terventions such as the role-out of HIV antiretroviral
drugs and vaccinations impractical [35]. Consequently,
the PNG paediatrics standard treatment guideline stipu-
lates that “It is everyone’s duty to ensure that all children
are vaccinated. Every health facility and every health
worker should ensure that children in their care are fully
immunised” [32]. This highlights the difficulties involved
in providing basic healthcare services in PNG and the
local guideline recommends opportunistic vaccination to
be carried out by all health workers which includes
medical researchers. Although critics may view this as
inappropriate inducement, contextualized to the resource-limited setting; the provision of basic healthcare services
while conducting research is an ethical obligation of all
health workers mandated by local authorities. This stance
is further supported by the Declaration of Helsinki which
clearly states that lack of healthcare services should not
justify not providing healthcare for patients than is gener-
ally available in a particular setting [26]. Provided there is
valid consent, meaning that the participant is adequately
informed, understands, and the informed consent is given
by a competent person [36], the risk of therapeutic mis-
conception and inappropriate inducement or coercion can
be minimised.
iv. An ethical obligation of funding agencies
In studies conducted in resource-limited settings, apart
from directly funding research activities, funding agencies
are increasingly recognising the importance of capacity
building in the host country. However, there is usually no
funding allocated to the cost of providing basic healthcare
services. From our perspectives as developing country re-
searchers, it is difficult to ethically conduct research with-
out providing basic healthcare services in such settings.
Consequently, funding agencies must be aware of indirect
costs that may include healthcare services that conform to
the standard of care practically attainable in the host
country [29]. This is an ethical responsibility that must be
recognised by funding agencies and researchers who have
an interest in conducting research in developing countries
[10]. Although it is not their responsibility to provide
healthcare services and study protocols often recommend
that patients be referred to existing healthcare facilities,
when accessibility and affordability of healthcare services
are limited or non-existent, referring patients may mean
subjecting them to sub-optimal patient-care that inevit-
ably increases the likelihood of an adverse outcome.
Therefore, study designs or limited resources in develop-
ing countries should not justify not providing basic
healthcare services in such situations.
Summary
Although integrating patient-care with clinical research
in developing countries appears as an attractive method
of conducting clinical research when resources are li-
mited, careful planning and consideration on the ethical
implications of such approach must be taken into con-
sideration. This argument is not to suggest that vulner-
able populations and poverty should justify a double
ethical standard. Instead, we argue that ethical principles
must be contextualised to the local setting, but a balance
between proper patient-care conforming to the highest
standard of healthcare practically attainable in a resource-
limited setting must also be carefully weighed against the
risk of ethical misconduct and harm to the local healthcare
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integration process can be minimised if the ultimate
allegiance of researchers is on patient-care; the input of
local ethics committees and institutions are considered;
and funding agencies acknowledge their ethical obligation
when conducting research in resource-limited settings.
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